Diss. (sammanfattning) Stockholm : Karolinska institutet, 2007. / Härtill 5 uppsatser.

Thesis (M.S.)--West Virginia University, 2009. / Title from document title page. Document formatted into pages; contains vii, 42 p. : ill. Includes abstract. Includes bibliographical references (p. 29-35).

Ziel der vorliegenden Promotionsarbeit war die Untersuchung von Sepsis-assoziierten Veränderungen des Arachidonsäure (AA)-Metabolismus und die Identifikation differentiell regulierter AA-Metabolite mit Prüfung ihres diagnostischen Potentials bei Patienten mit Sepsis unter Anwendung eines in-vitro Lipopolysaccharid (LPS) Vollblutaktivierungs-Modells. In Zellüberständen von nicht-aktiviertem und LPS-aktiviertem Heparinblut (25 Sepsis- Patienten, 15 Gesunde) wurden AA-Metabolite mittels Flüssigkeitschromatographie-Tandem- Massenspektrometrie analysiert. In einer unabhängigen Kohorte (10 Sepsis-Patienten, 3 Gesunde) wurden nach RNA-Isolation aus Zellmaterial zusätzlich Target-Gene des AAMetabolismus (Cyclooxygenase (COX)-2 und mikrosomale Prostaglandin-E-Synthase (mPGES)-1 mittels quantitativer Reverse Transkriptase-Polymerase Kettenreaktion (RT-PCR) untersucht. Es konnte eine differentielle Freisetzung von AA, AA-Analoga und der COX-assoziierten Metabolite Prostaglandin (PG) E2, 11-Hydroxyeicosatetraensäure (HETE) und Thromboxan (TX) B2 zwischen Patienten und gesunden Kontrollpersonen gezeigt werden. Sepsis-Patienten wiesen dabei gegenüber Gesunden eine deutlich reduzierte Freisetzung von AA und den COXassoziierten Metaboliten 11-HETE und PGE2 auf. Das Ausmaß der reduzierten Mediatorenfreisetzung bei Sepsis-Patienten war mit der Schwere der Erkrankungssymptomatik und dem klinischen Outcome assoziiert. Auf Genexpressionsebene zeigte sich eine reduzierte Induzierbarkeit der COX-2 mRNA-Expression bei Sepsis-Patienten gegenüber Gesunden, jedoch eine erhaltene Induzierbarkeit auf der Ebene der mPGES-1.

Submitted by Ana Maria Fiscina Sampaio (fiscina@bahia.fiocruz.br) on 2013-11-06T17:53:22Z No. of bitstreams: 1 Theo de Araújo Santos Corpusculos lipídios e eicosanoides nos momentos iniciais...pdf: 8310647 bytes, checksum: 79f3b7453e377fceaa874dda0b7901fe (MD5) / Made available in DSpace on 2013-11-06T17:53:22Z (GMT). No. of bitstreams: 1 Theo de Araújo Santos Corpusculos lipídios e eicosanoides nos momentos iniciais...pdf: 8310647 bytes, checksum: 79f3b7453e377fceaa874dda0b7901fe (MD5) Previous issue date: 2013 / Universidade Federal da Bahia. Faculdade de Medicina da Bahia. Salvador, BA, Brasil / Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil / Corpúsculos lipídicos são organelas citoplasmáticas envolvidas na produção de eicosanoides em leucócitos. Eicosanoides como as prostaglandinas têm sido envolvidos no controle da resposta inflamatória e imunológica. A saliva de Lutzomyia longipalpis participa do estabelecimento e desenvolvimento da doença pela modulação das respostas hemostática, imunológica e inflamatória do hospedeiro favorecendo a infecção. Entretanto, o papel dos eicosanoides nos momentos iniciais da infecção por Leishmania ainda não foi esclarecido, assim como a participação da saliva neste contexto. Aqui, nós investigamos o papel dos eicosanoides induzidos pela saliva de L. longipalpis e produzidos pela Leishmania infantum chagasi na infecção. O sonicado de glândula salivar (SGS) de L. longipalis induziu um aumento no número de CLs em macrófagos de maneira dose e tempo dependente, o qual esteve correlacionado com o aumento de PGE2 nos sobrenadante de cultura. As enzimas COX- 2 e PGE-sintase foram co-localizadas nos CLs induzidos pela saliva e a produção de PGE2 foi reduzida pelo tratamento com NS-398, um inibidor de COX-2. Nós verificamos que o SGS rapidamente estimulou a fosforilação de ERK-1/2 e PKC-α e a inibição farmacológica dessas vias inibiu a produção de PGE2 pelos macrófagos estimulados com SGS. Em seguida, nós avaliamos o efeito da saliva de L. longipalpis sobre a produção de eicosanoides durante a infecção por L. i. chagasi no modelo peritoneal murino. Nós observamos que a saliva aumentou a viabilidade intracelular de L. i. chagasi tanto em neutrófilos como em neutrófilos recrutados para a cavidade peritoneal. As células recrutadas para cavidade peritoneal apresentaram maiores níveis da relação PGE2/LTB4 e o pré-tratamento com NS-398 reverteu o efeito da saliva sobre a viabilidade intracelular dos parasitas. Parasitas como Leishmania são capazes de produzir PGs utilizando uma maquinaria enzimática própria. Neste estudo nós descrevemos a dinâmica de formação e a distribuição celular dos CLs em L. i. chagasi bem como a participação desta organela na produção de PGs. A quantidade de CLs aumentou durante a metaciclogênese assim como a expressão de PGF2α sintase (PGFS), sendo esta enzima co-localizada nos CLs. A adição de ácido araquidônico AA à cultura de L. i. chagasi aumentou a quantidade de CLs por parasita, bem como a secreção de PGF2α. A infecção com as diferentes formas de L. i. chagasi não foi capaz de estimular a formação de CLs na célula hospedeira. Por outro lado, os parasitas intracelulares apresentaram maiores quantidades de CLs. A infecção estimulou uma rápida expressão de COX-2, mas não foi detectado aumento na produção de PGF2α nos sobrenadantes. Por fim, nós verificamos a presença do receptor de PGF2α (FP) nos vacúolos parasitóforos de macrófagos infectados com L. i. chagasi. O prétratamento das células com um antagonista do receptor FP inibiu os índices de infecção de forma dose-dependente. Em conjunto, nossos dados apontam que os eicosanoides desempenham um papel crucial para evasão da resposta imune durante os momentos iniciais da infecção por L. i. chagasi com diferentes contribuições do parasita, do vetor e da célula hospedeira neste contexto. / Lipid bodies (LB) are cytoplasmic organelles involved in eicosanoid production in leukocytes. Eicosanoids as prostaglandins (PG) have been implicated in the inflammatory and immune response control. Sand fly saliva participates of the establishment and development of the disease by modulation of haemostatic, inflammatory and immunological response of the host favoring the infection. However, the role of eicosanoids in the early steps of the infection remains to be investigated as well as the role of the sand fly in this context. Herein, we investigated the role of eicosanoids trigged by L. longipalpis saliva and produced by Leishmania infantum chagasi during infection. L. longipalpis salivary gland sonicate (SGS) induced an increase of LB number in the macrophages of a dose and time dependent manner, which was correlated with an increase of PGE2 release in the culture supernatants. Furthermore, COX-2 and PGE-synthase co-localized within the LBs induced by L. longipalpis saliva and PGE2 production was abrogated by treatment with NS-398, a COX-2 inhibitor. We verified SGS rapidly triggered ERK-1/2 and PKC-α phosphorylation, and blockage of the ERK-1/2 and PKC-α pathways inhibited the SGS effect on PGE2 production by macrophages. Next, we evaluated the effect of the L. longipalpis saliva in the eicosanoid production during L. i. chagasi in the murine peritoneal model. We observed SGS increased parasite viability inside recruited monocytes and neutrophils. In this regarding, SGS-recruited cells to peritoneal cavity displayed an increase in the levels of PGE2/LTB4 and the pre-treatment with NS-398 abrogated the sand fly saliva effect on parasite viability. Parasites as Leishmania are capable to produce PGs using enzymatic machinery itself. Parasite LBs amounts increased during metacyclogensis as well as the PGF2α synthase (PGFS) expression and this enzyme was colocalized on LBs. Exogenous addition of aracdonic acid in the Leishmania cultures increased LB number per parasite and PGF2α release. Macrophage infection with different forms of L. i. chagasi was not able to stimulate LB formation in the host cell. Notwithstanding, Leishmania infection upregulated COX-2 expression but this was not followed by PGF2α release by macrophages. We detected PGF2α receptor (FP) on the Leishmania PV surface. In addition, the pre-treatment of the host cells with a selective antagonist of FP, dramatically hampered Leishmania infection in a dose dependent manner. In set, our data point out a crucial role for eicosanoids to immune response evasion during early steps of L. i. chagasi infection with different contributions of parasite, vector and host cells in this context.

Este estudo teve por objetivos: i) caracterizar o influxo leucocitário induzido pelo veneno de Bothrops insularis (VBi); ii) avaliar a liberação de PGD2 e PGE2, TXA2 e LTB4 e das quimiocinas MCP-1 e KC induzida pelo VBi; iii) analisar a ação do VBi quanto a expressão protéica das enzimas ciclooxigenases (COX -1 e -2) e iv) avaliar a participação dos metabólitos das COX-1 e -2 e 5-LO no influxo leucocitário. O VBi causou aumento de leucócitos circulantes e do influxo de leucócitos PMN e MN para o local de sua injeção. Ainda, veneno induziu a liberação de PGD2, PGE2, TXA2 e LTB4, da MCP-1, mas não da KC, além da expressão protéica de COX-2. O tratamento dos animais com indometacina, etoricoxibe ou zileuton inibiu o influxo de leucócitos induzido pelo VBi na 12ª h. Em conclusão, o VBi tem capacidade de induzir influxo de leucócitos e liberação de mediadores inflamatórios para o local de sua injeção. O influxo leucocitário relaciona-se aos metabólitos das COX -1 e -2, 5-LO, da MCP-1 e do aumento de leucócitos circulantes / In this study the effects of Bothrops insularis venom (BiV) on the leukocyte influx, on the circulating leukocyte numbers and release of mediators, such as PGD2, PGE2, TXA2, LTB4, MCP-1 and KC into the local of its injection. Moreover, the role of eicosanoids in the BiV- induced leukocyte influx was assessed by selected pharmacological treatments. PMN were accumulated from 6 up to 24 h and MN cells from 3 up to 72 h when injected into the peritoneal cavity of mice. Moreover, BiV increased blood leukocyte at 3 h after injection and incresed the levels of PGD2, PGE2, TXA2, LTB4, MCP-1 at distinct periods of time. In addition, BiV induced the protein expression of COX-2 from 1 up to 12 h and the BiV-induced leukocyte influx was reduced by indomethacin or etoricoxib or zileuton at 12 h after injection. In conclusion, BiV is able to induce leukocyte influx and increase of blood leukocyte numbers. Moreover, the ability of BiV to induce expression of COX-2 and release of inflammatory mediators is relevant for the leukocytes influx into the local of its injection

The World Health Organization classifies glioblastoma (GBM) as a type IV astrocytoma, making it one of the most fatal tumors that exists. Despite the advances in chemotherapy, surgery, and radiation treatments that improve a patients length of survival, the overall trajectory of the disease remains unchanged. It has been shown that GBM cells produce significant levels of prostaglandins, including prostaglandin D2 (PGD2). PGD2 possesses pro- and anti-tumorigenic properties. Hence, a more complete understanding of PGD2 activity in GBM could yield more effective treatments against GBM. Through techniques like RT-PCR, immunohistochemistry, and HPLC tandem mass spectrometry, we were able to confirm the presence of the PGD2 synthesis in GBM cell lines. We treated GBM cell lines with various concentrations of exogenous PGD2 over 72 hours and observed its effects on cell count, apoptosis, mitosis and viability. Our results suggest that PGD2 possesses contradictory functions in GBM depending on concentration (mM PGD2 vs. nM PGD2) and receptor activation. / A Organização Mundial de Saúde classifica glioblastoma (GBM) como um astrocitoma tipo IV, fazendo uns dos tumores mais fatais que existe. A pesar dos avanços em quimioterapia, cirurgia e radioterapia que melhoram a longevidade de sobrevivência, a trajetória geral da doença permanece imutável. Tem sido demonstrado que células de GBM produzem níveis significativos de prostaglandinas, incluindo prostaglandina D2 (PGD2). PGD2 possui propriedades pro- e anti-tumorigenicos. Então, um entendimento mais completo da atividade de PGD2 em GBM pode gerar tratamentos mais efetivos. Através de técnicas como RT-PCR, imunohistoquimicas e HPLC espectrometria de massa em tandem, conseguimos confirmar a presença da síntese de PGD2 em linhagens de GBM. Tratamos linhagens de GBM com concentrações variáveis de PGD2 exógeno durante 72 horas e observamos seus efeitos na contagem de células, apoptose, mitose e viabilidade. Nossos resultados sugerem que PGD2 possui funções opostas em GBM dependendo em concentração (mM PGD2 vs. nM PGD2) e ativação de receptores.

O glioblastoma multiforme (GBM) é uma neoplasia do sistema nervoso central (SNC), caracterizada por uma elevada capacidade proliferativa e migratória. O desenvolvimento do tumor provoca uma remodelação da matriz extracelular (MEC) que facilita a migração tumoral. Eicosanóides são moléculas lipídicas importantes na carcinogênese e a sua síntese está correlacionada com o grau de desenvolvimento do tumor. As prostaglandinas são eicosanóides envolvidas na estimulação da angiogênese, na adesão celular e proliferação celular. Este estudo tem por objetivo avaliar in vitro o efeito da PGE2 na expressão moléculas da MEC e das moléculas de adesão envolvidas na migração, em células U87MG e U251MG. As células U251MG e U87MG foram tratadas com PGE2 (10µM) e Ibuprofeno (25µM), por um período 48hs. As proteínas da MEC foram analisadas por RT-qPCR após o tratamento. Foram realizadas reações de imunohistoquímica para as moléculas da MEC. As alterações foram encontradas na expressão de laminina, fibronectina, colágeno tipo IV e as integrinas αv , α3 e α5 para células U87MG . Observamos imunomarcação nas linhas celulares para colágeno tipo IV, laminina e fibronectina. Concluímos que o tratamento com IBU e PGE2, afeta a expressão gênica de moléculas de MEC. / Glioblastoma Multiforme (GBM) is a neoplasm of the central nervous system (CNS), characterized by a high proliferative and migratory capacity. Tumor development leads to extracellular matrix (ECM) remodeling and facilitating the migration of these cells. Eicosanoids are important lipid molecules in carcinogenesis, and their synthesis often correlates with the degree of tumor development. Prostaglandins are eicosanoids involved in the stimulation of angiogenesis, cell adhesion and cell proliferation. This study is aimed to evaluate the expression of several ECM molecules involved in migration after altering the concentration of prostaglandins, using human glioma cell lines as an in vitro model. The cell lines U87MG and U251MG were treated with PGE2 (10µM) and Ibuprofen (25µM), for a predetermined period of 48hs. Proteins involved in extracellular matrix were analyzed by RT-qPCR after treatment in vitro. Immunohistochemical reactions were also performed for the ECM molecules. Changes were found in the expression of laminin, fibronectin, type IV collagen and αv, α3 and α5 integrins in cells U87MG. We observed immunostaining in cell lines to type IV collagen, laminin and fibronectin. In conclusion, Ibuprofen and PGE2, affects gene expression of ECM molecules.

Lipoxygenases (LOXs), cytochromes P450 (CYPs) and cyclooxygenases (COXs) catalyze peroxidation of unsaturated fatty acids. In humans they convert arachidonic acid into a variety of eicosanoids, which play a role in all inflammatory responses, cardiovascular and kidney diseases, Alzheimer's, cancer and other ailments. Blocking one pathway can prompt the body to switch to the available alternatives. In contrast to CYP and COX, LOX has a non-heme iron co-factor. Several LOXs are produced or stress-induced in the human body. They share the same mechanism, but differ in sequence causing catalysis on the same substrate to be regio- and stereospecific. The action of 15-LOXs could be pro- or anti-inflammatory, and pro- or anti-carcinogenic. Depending on the dose, LOXs inhibitors can induce or inhibit other oxygenases. Inhibition of these enzymes presents a great challenge in solving the problem of how to control their action and treat diseases, without causing severe side effects and maintaining/restoring a delicate equilibrium between them. Research on CYPs and COXs is more advanced, while studies of LOXs are lagging behind. This article presents a brief review about LOX structures and inhibition, their involvement in human diseases, and their interplay with other oxidoreductases.

Lipids are increasingly recognized as bioactive mediators of extracellular vesicle (EV) functions. However, while EV proteins and nucleic acids are well described, EV lipids are insufficiently understood due to lack of adequate quantitative methods. We adapted an established targeted and quantitative mass spectrometry (LC-MS/MS) method originally developed for analysis of 94 eicosanoids and seven polyunsaturated fatty acids (PUFA) in human plasma. Additionally, the influence of freeze–thaw (FT) cycles, injection volume, and extraction solvent were investigated. The modified protocol was applied to lipidomic analysis of differently polarized macrophage-derived EVs. We successfully quantified three PUFAs and eight eicosanoids within EVs. Lipid extraction showed reproducible PUFA and eicosanoid patterns. We found a particularly high impact of FT cycles on EV lipid profiles, with significant reductions of up to 70%. Thus, repeated FT will markedly influence analytical results and may alter EV functions, emphasizing the importance of a standardized sample pretreatment protocol for the analysis of bioactive lipids in EVs. EV lipid profiles differed largely depending on the polarization of the originating macrophages. Particularly, we observed major changes in the arachidonic acid pathway. We emphasize the importance of a standardized sample pretreatment protocol for the analysis of bioactive lipids in EVs.

no / Chronic wounds often result from prolonged inflammation involving excessive polymorphonuclear leukocyte activity. Studies show that the omega-3 polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acids found in fish oils generate bioactive lipid mediators that reduce inflammation and polymorphonuclear leukocyte recruitment in numerous inflammatory disease models. The purpose of this study was to test the hypotheses that boosting plasma levels of eicosapentaenoic and docosahexaenoic acids with oral supplementation would alter lipid mediator levels in acute wound microenvironments and reduce polymorphonuclear leukocyte levels. Eighteen individuals were randomized to 28 days of either eicosapentaenoic + docosahexaenoic acid supplementation (Active Group) or placebo. After 28 days the Active Group had significantly higher plasma levels of eicosapentaenoic (p<0.001) and docosahexaenoic acid (p<0.001) than the Placebo Group and significantly lower wound fluid levels of two 15-lipoxygenase products of omega-6 polyunsaturated fatty acids, [9- hydroxyoctadecadienoic (HODE) acid (p = 0.033) and15-hydroxyeicosatrienoic acid (HETrE) (p = 0.006)], at 24 hours post wounding. The Active Group also had lower mean levels of myeloperoxidase, a leukocyte marker, at 12 hours and significantly more re-epithelialization on Day 5 post wounding. We suggest that lipid mediator profiles can be manipulated by altering polyunsaturated fatty acid intake to create a wound microenvironment more conducive to healing.